Aliyacyac, Sylvia I.
HRN: 02-36-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/13/2022
07/20/2022
IVT
500 Mg
Q8
Community Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes